Golimumab in the treatment of extra-skeletal manifestations of ankylosing spondylitis
Extra-skeletal manifestations (EMs) of ankylosing spondylitis (AS) can occur and proceed in parallel with inflammatory changes in the joints and spine and often dominate in the clinical picture of AS, determining its high activity and significantly worsening the quality of life in patients. In a num...
Main Author: | A. B. Demina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2019-10-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/968 |
Similar Items
-
Efficacy of golimumab in treating uveitis in patients with ankylosing spondylitis
by: T. V. Dubinina, et al.
Published: (2016-09-01) -
CASE OF SEVERE JUVENILE-ONSET ANKYLOSING SPONDYLITIS IN A PATIENT WITH RECURRENT UVEITIS
by: K. A. Gamayunova, et al.
Published: (2019-05-01) -
The abilities of golimumab in the therapy of ankylosing spondylitis
by: Sh. F. Erdes
Published: (2014-09-01) -
IMPACT OF THE THERAPY WITH TUMOR NECROSIS FACTOR α INHIBITORS ON THE FREQUENCY OF UVEITIS EXACERBATIONS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: Alla A Godzenko, et al.
Published: (2014-03-01) -
Time course of changes in the clinical and instrumental manifestations of coxitis in patients with ankylosing spondylitis during golimumab therapy: a GO-COX study. Preliminary results
by: Sh. Erdes, et al.
Published: (2019-07-01)